Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
I'll present the eligibility criteria for each of the four groups in this trial separately, as each group has different requirements.
GROUP 1: Normal (Healthy) Eyes Group
Who might be able to join this trial:
- People who are 22 years of age or older at the time of signing the consent form
- People who are able to understand and willing to sign a written consent form agreeing to take part
- People whose eyes appear normal during an eye examination at the study visit, checked using a special lens
- People whose best corrected vision (with glasses or contact lenses if needed) is 20/40 or better in each eye at the study visit
Who may not be able to join:
- People who are unable to tolerate eye imaging procedures
- People whose eye imaging cannot produce usable scan results due to cloudiness in the eye or other reasons
- People who have a health condition or situation that the study doctor believes could put them at significant risk, affect the study results, or make it difficult for them to fully take part
- People who have any eye disease or condition in either eye, except for cataracts
GROUP 2: Glaucoma Group
Who might be able to join this trial:
- People who are 22 years of age or older at the time of signing the consent form
- People who are able to understand and willing to sign a written consent form agreeing to take part
- People whose best corrected vision (with glasses or contact lenses if needed) is 20/40 or better in the study eye
- People who have had a visual field test showing signs of glaucoma-related vision loss, either within the past year or on the day of the study visit — specifically, a cluster of three or more weak spots in expected areas of the visual field, with at least one being significantly weak, or a result flagged as "outside normal limits" on a specific glaucoma test
- People who show physical signs of glaucoma damage to the optic nerve or the nerve fibre layer around it — such as thinning, narrowing, or notching of the nerve tissue (particularly at the top or bottom of the optic disc, with or without a small bleed), or a noticeable difference in nerve tissue between the two eyes
Who may not be able to join:
- People who are unable to tolerate eye imaging procedures
- People whose eye imaging cannot produce usable scan results due to cloudiness in the eye or other reasons
- People who have a health condition or situation that the study doctor believes could put them at significant risk, affect the study results, or make it difficult for them to fully take part
- People who do not have a reliable visual field test result from within the past year in the study eye — where "reliable" means the test did not show too many fixation errors, false positives, or false negatives (each must be 33% or lower) (confirm with trial site)
GROUP 3: Retinal Disease Group
Who might be able to join this trial:
- People who are 22 years of age or older at the time of signing the consent form
- People who are able to understand and willing to sign a written consent form agreeing to take part
- People whose best corrected vision (with glasses or contact lenses if needed) is 20/400 or better in the study eye
- People who have been diagnosed by a study doctor with a retinal condition — this may include conditions such as macular degeneration (including drusen, geographic atrophy, or abnormal blood vessel growth), diabetic macular swelling, diabetic retinopathy, a macular hole, a membrane growing over the macula, central serous retinopathy, blockages in the blood vessels of the eye, or other retinal conditions
Who may not be able to join:
- People who are unable to tolerate eye imaging procedures
- People whose eye imaging cannot produce usable scan results due to cloudiness in the eye or other reasons
- People who have a health condition or situation that the study doctor believes could put them at significant risk, affect the study results, or make it difficult for them to fully take part
GROUP 4: Cornea Group
Who might be able to join this trial:
- People who are 22 years of age or older at the time of signing the consent form
- People who are able to understand and willing to sign a written consent form agreeing to take part
- People who have one of the following corneal (front surface of the eye) conditions: a corneal disease such as Fuchs' dystrophy or similar, keratoconus (a cone-shaped cornea), a corneal transplant, previous laser eye surgery such as LASIK or similar, dry eye syndrome, or a history of wearing contact lenses for more than one year
- People whose best corrected vision (with glasses or contact lenses if needed) is 20/400 or better in the study eye
Who may not be able to join:
- People who are unable to tolerate eye imaging procedures
- People whose eye imaging cannot produce usable scan results due to cloudiness in the eye or other reasons
- People who have a health condition or situation that the study doctor believes could put them at significant risk, affect the study results, or make it difficult for them to fully take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Micahel Chaglasian, OD, Illinois College of Optometry
Phone: 6198067636
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Agreement results and Precision Results
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.